NEA 0.00% $2.10 nearmap ltd

There doesn't appear to be much substance to the patent...

  1. 1,180 Posts.
    lightbulb Created with Sketch. 290
    There doesn't appear to be much substance to the patent infringement claim. Eagleview can see Nearmap gaining traction and real estate with technology and a product which is superior in every way.

    Eagleview vs Verisk was a totally different case. Are we all aware that Verisk attempted to take over Eagleview but was knocked back due to the possibility of it creating a "monopoly" in the market? So during takeover talks and due diligence Verisk and Eagleview were very much in each others back pocket. Honestly, the case notes reads like a drama novel.

    Eagleview vs Nearmap is just preventing the inevitable- US dominance by Nearmap.
 
watchlist Created with Sketch. Add NEA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.